江湖电竞博注
CNC
US
$
-1.86
-2.02%
After Hours
$
90.13
After Hours Volume:
87.69K
| Close | Chg | Chg % |
|---|---|---|
| $91.99 | 0.73 | 0.80% |
Volume: 2.17M
65 Day Avg: 2.91M
91.18
Day Range
92.75
59.67
52 Week Range
98.53
Overview
CNC Overview
Key Data
- Open $92.04
- Day Range 91.18 - 92.75
- 52 Week Range 59.67 - 98.53
- Market Cap $52.16B
- Shares Outstanding 571.53M
- Public Float 560.09M
- Beta 0.96
- Rev. per Employee $1.905M
- P/E Ratio 29.26
- EPS $3.14
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 8.08M 08/15/22
- % of Float Shorted 1.44%
- Average Volume 2.91M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings
21
Full Ratings
Recent News
Centene raises profit outlook, will reduce real estate footprint as it adopts modern, flexible work environment
Shares of Centene Corp. rallied 1.8% in premarket trading Friday, after the health care company raised its full-year profit and revenue outlook and added $3.0 billion to its stock repurchase program. The company also said...
Centene to record $750 mln-$800 mln in impairments for a 65% decrease in domestic leased space
Centene raises 2022 adj. EPS outlook to $5.55-$5.70 from $5.40-$5.55
Centene sets $3 bln stock repurchase program
Centene downgraded to neutral from buy at BofA Securities
Centene profit and revenue rise above expectations, full-year outlook lifted
Centene Corp. reported Tuesday first-quarter profit and revenue that rose above expectations, amid strength in its Medicare and Medicaid businesses, and raised its full-year earnings outlook. The health care services comp...
Centene now sees full-year revenue $139.9 bln to $141.9 bln
Centene now sees full-year adj. EPS $5.40 to $5.55
Centene Q1 revenue $37.185 bln vs. $29.983 bln a year ago; FactSet consensus $34.520 bln
Centene Q1 adj. EPS $1.83; FactSet consensus $1.68
Centene Q1 EPS $1.44 vs. $1.19 a year ago
Centene (CNC) Dips More Than Broader Markets: What You Should Know
Centene (CNC) closed at $88.33 in the latest trading session, marking a -1.91% move from the prior day.
on Zacks.com
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
on Zacks.com
Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa
Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.
on Zacks.com
Is Centene (CNC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and mo...
on Zacks.com
Centene (CNC) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Centene (CNC) closed at $89.74, marking a -1.59% move from the previous day.
on Zacks.com
Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties
Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.
on Zacks.com
5 “Strong Buy” Stocks to Buy This Week
on StockNews.com
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022
on Benzinga.com
Should You Buy This Market-Beating Blue Chip Stock?
on Motley Fool
If You Invested $1000 in Centene 10 Years Ago, This Is How Much You'd Have Now
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
on Zacks.com
10 Health Care Stocks With Whale Alerts In Today's Session
on Benzinga.com
Is Alimera Sciences (ALIM) Outperforming Other Medical Stocks This Year?
Here is how Alimera Sciences (ALIM) and Centene (CNC) have performed compared to their sector so far this year.
on Zacks.com
2 Stocks You Can Use to Ride out a Recession
on StockNews.com
4 Stocks You’ll Be Glad You Bought
on StockNews.com
Humana (HUM) to Acquire Inclusa to Aid Medicaid Customer Base
Humana (HUM) inks a deal to purchase Wisconsin-based Inclusa to grow its Medicaid membership and fortify its footprint in the state.
on Zacks.com
Humana (HUM) Closes $2.8B Kindred Hospice Divestment to CD&R
Humana (HUM) retaining the remaining 40% stake will likely enable it to gain from the standalone company's long-term success.
on Zacks.com
Select Medical (SEM) Shares Dip on Q2 Earnings & Revenue Miss
Select Medical's (SEM) second-quarter earnings take a hit from escalating expenses and reduced admissions within the Critical Illness Recovery Hospital segment.
on Zacks.com
5 Strong Uptrend Stocks to Buy on the Next Dip
on InvestorPlace.com
Top 5 2nd Quarter Trades of Sivik Global Healthcare LLC
Top 5 2nd Quarter Trades of Sivik Global Healthcare LLC
on GuruFocus.com
Centene Corp.
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| HCA Healthcare Inc. |
|
$62.06B |
| IQVIA Holdings Inc. |
|
$41.24B |
| Laboratory Corp. of America Holdings |
|
$21.54B |
| Icon PLC |
|
$18.08B |
| Teladoc Health Inc. |
|
$5.24B |
| Quest Diagnostics Inc. |
|
$15.18B |
| DaVita Inc. |
|
$8.33B |
| Universal Health Services Inc. Cl B |
|
$6.65B |
| Oak Street Health Inc. |
|
$6.8B |